Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Mathew

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Transplantation|July 26, 2013
Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humansJosh Levitsky, Joshua Miller, Xuemei Huang, et al.
Frontiers in Immunology|March 8, 2024
Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulationJames M Mathew, Jes M Sanders, Robert Cirocco, et al.
Human Immunology|February 27, 2018
Transcriptomic studies in tolerance: Lessons learned and the path forwardSunil M Kurian, Thomas C Whisenant, James M Mathew, et al.
Plos One|June 19, 2015
Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsOpas Traitanon, James M Mathew, Giovanna La Monica, et al.
Plos One|June 9, 2016
Immunoregulatory Effects of Everolimus on In Vitro Alloimmune ResponsesJosh Levitsky, Joshua Miller, Xuemei Huang, et al.
Frontiers in Immunology|June 7, 2021
Tackling Chronic Kidney Transplant Rejection: Challenges and PromisesXingqiang Lai, Xin Zheng, James M Mathew, et al.
Plos One|November 4, 2014
Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction cultureRyan O Emerson, James M Mathew, Iwona M Konieczna, et al.
Human Immunology|November 20, 2020
Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantationJames M Mathew, Sunil Kurian, Paolo Cravedi, et al.
Human Immunology|March 1, 2016
Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulinAnnapoorani Veerappan, Lisa B VanWagner, James M Mathew, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2026
The DC1 Conundrum: Do Type I Dendritic Cells Make or Break Allograft Tolerance?Ivana R Shen, Shareni Jeyamogan, Rebecca T L Jones, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Transplantation|July 26, 2013
Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humansJosh Levitsky, Joshua Miller, Xuemei Huang, et al.
Frontiers in Immunology|March 8, 2024
Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulationJames M Mathew, Jes M Sanders, Robert Cirocco, et al.
Human Immunology|February 27, 2018
Transcriptomic studies in tolerance: Lessons learned and the path forwardSunil M Kurian, Thomas C Whisenant, James M Mathew, et al.
Plos One|June 19, 2015
Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsOpas Traitanon, James M Mathew, Giovanna La Monica, et al.
Plos One|June 9, 2016
Immunoregulatory Effects of Everolimus on In Vitro Alloimmune ResponsesJosh Levitsky, Joshua Miller, Xuemei Huang, et al.
Frontiers in Immunology|June 7, 2021
Tackling Chronic Kidney Transplant Rejection: Challenges and PromisesXingqiang Lai, Xin Zheng, James M Mathew, et al.
Plos One|November 4, 2014
Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction cultureRyan O Emerson, James M Mathew, Iwona M Konieczna, et al.
Human Immunology|November 20, 2020
Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantationJames M Mathew, Sunil Kurian, Paolo Cravedi, et al.
Human Immunology|March 1, 2016
Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulinAnnapoorani Veerappan, Lisa B VanWagner, James M Mathew, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2026
The DC1 Conundrum: Do Type I Dendritic Cells Make or Break Allograft Tolerance?Ivana R Shen, Shareni Jeyamogan, Rebecca T L Jones, et al.
Pageof 6